How Rapamycin Affects T Cells and Memory Cell Formation
Author Information
Author(s): He Shan, Kato Koji, Jiang Jiu, Wahl Daniel R., Mineishi Shin, Fisher Erin M., Murasko Donna M., Glick Gary D., Zhang Yi
Primary Institution: University of Michigan
Hypothesis
The metabolic phenotype of rapamycin-treated CD8+ T cells enhances their ability to generate long-lasting memory cells.
Conclusion
Rapamycin-treated CD8+ T cells can survive better and produce more long-lived memory T cells compared to untreated cells.
Supporting Evidence
- Rapamycin-treated T cells produced 5-fold more long-lived memory T cells than untreated controls.
- These T cells showed increased glycolysis and oxidative phosphorylation.
- Rapamycin treatment improved T cell survival during glucose and growth factor withdrawal.
Takeaway
Researchers found that a drug called rapamycin helps certain immune cells, called T cells, live longer and become better at remembering infections.
Methodology
The study used CD8+ T cells from mice, activated them with a virus peptide, and treated them with rapamycin to assess their metabolic changes and memory cell generation.
Limitations
The study primarily focused on a specific type of T cell and may not generalize to all immune cells.
Participant Demographics
Mice were used in the study, specifically T cell receptor transgenic mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website